Aptevo Therapeutics Inc
APVO
$1.62-4.71%
End of day · as of Oct 17, 2026, 2:00 AM ET
Mkt cap
$9.93M
EV/Sales
-3.75
P/E ratio
N/A
FY2022 Revenue
$3.11M
EPS (H1 2026)
$-11.19
Gross Margin (FY2022)
N/A
Profit Margin (FY2022)
257.77%
Beta
5.73
Div yield
N/A
Sector
Healthcare
Aptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
Latest reported APVO revenue for 2022-12-31 was $3.1M. Net income was $8.0M. APVO currently screens at market cap $9.9M.
Use this APVO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full APVO income, balance, and cash tables.
Aptevo Therapeutics Inc (APVO) is a biotechnology company in the Healthcare sector.
Latest cached Aptevo Therapeutics Inc (APVO) revenue for Dec 31, 2022 was $3.1M. Net income was $8.0M. Statements: https://lician.com/financials/apvo
Aptevo Therapeutics Inc (APVO) market capitalization is $9.9M on the latest cached snapshot.
Aptevo Therapeutics Inc (APVO) cached previous close $1.70; day range $1.62 – $1.73; volume 30,848. Session quote: https://lician.com/quote/apvo
Aptevo Therapeutics Inc (APVO) latest cached earnings event is "APVO earnings" on Aug 17, 2026. Earnings calendar: https://lician.com/earnings
The latest cached APVO filing is 8-K · Oct 14, 2026. Filings: https://lician.com/sec/apvo